Literature DB >> 19949091

Distribution, persistence, and efficacy of adoptively transferred central and effector memory-derived autologous simian immunodeficiency virus-specific CD8+ T cell clones in rhesus macaques during acute infection.

Jacob T Minang1, Matthew T Trivett, Diane L Bolton, Charles M Trubey, Jacob D Estes, Yuan Li, Jeremy Smedley, Rhonda Pung, Margherita Rosati, Rashmi Jalah, George N Pavlakis, Barbara K Felber, Michael Piatak, Mario Roederer, Jeffrey D Lifson, David E Ott, Claes Ohlen.   

Abstract

Plasma viremia decreases coincident with the appearance of virus-specific CD8(+) T cells during acute HIV or SIV infection. This finding, along with demonstrations of viral mutational escape from CD8(+) T cell responses and transient increase in plasma viremia after depletion of CD8(+) T cells in SIV-infected monkeys strongly suggest a role for CD8(+) T cells in controlling HIV/SIV. However, direct quantitative or qualitative correlates between CD8(+) T cell activity and virus control have not been established. To directly assess the impact of large numbers of virus-specific CD8(+) T cells present at time of SIV infection, we transferred in vitro expanded autologous central and effector memory-derived Gag CM9-, Nef YY9-, and Vif WY8-specific CD8(+) T cell clones to acutely infected rhesus macaques. The cells persisted in PBMCs between 4 and 9 d, but were not detected in gut-associated lymphoid tissue or lymph nodes. Interestingly, a high frequency of the infused cells localized to the lungs, where they persisted at high frequency for >6 wk. Although persisting cells in the lungs were Ag reactive, there was no measurable effect on virus load. Sequencing of virus from the animal receiving Nef YY9-specific CD8(+) T cells demonstrated an escape mutation in this epitope <3 wk postinfection, consistent with immune selection pressure by the infused cells. These studies establish methods for adoptive transfer of autologous SIV-specific CD8(+) T cells for evaluating immune control during acute infection and demonstrate that infused cells retain function and persist for at least 2 mo in specific tissues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19949091      PMCID: PMC2797560          DOI: 10.4049/jimmunol.0902410

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

Review 1.  Immune control and prevention of chronic Friend retrovirus infection.

Authors:  Kim J Hasenkrug; Ulf Dittmer
Journal:  Front Biosci       Date:  2007-01-01

2.  Vaccine-induced T cells control reversion of AIDS virus immune escape mutants.

Authors:  Caroline S Fernandez; Miranda Z Smith; C Jane Batten; Robert De Rose; Jeanette C Reece; Erik Rollman; Vanessa Venturi; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

3.  Efficient inhibition of SIV replication in rhesus CD4+ T-cell clones by autologous immortalized SIV-specific CD8+ T-cell clones.

Authors:  Jacob T Minang; Eugene V Barsov; Fang Yuan; Matthew T Trivett; Michael Piatak; Jeffrey D Lifson; David E Ott; Claes Ohlen
Journal:  Virology       Date:  2008-02-20       Impact factor: 3.616

Review 4.  Toward an AIDS vaccine.

Authors:  Bruce D Walker; Dennis R Burton
Journal:  Science       Date:  2008-05-09       Impact factor: 47.728

5.  The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape.

Authors:  John T Loffredo; Benjamin J Burwitz; Eva G Rakasz; Sean P Spencer; Jason J Stephany; Juan Pablo Giraldo Vela; Sarah R Martin; Jason Reed; Shari M Piaskowski; Jessica Furlott; Kim L Weisgrau; Denise S Rodrigues; Taeko Soma; Gnankang Napoé; Thomas C Friedrich; Nancy A Wilson; Esper G Kallas; David I Watkins
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

6.  Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.

Authors:  Carolina Berger; Michael C Jensen; Peter M Lansdorp; Mike Gough; Carole Elliott; Stanley R Riddell
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

7.  Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs.

Authors:  Takamasa Ueno; Yuka Idegami; Chihiro Motozono; Shinichi Oka; Masafumi Takiguchi
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

8.  Transduction with human telomerase reverse transcriptase immortalizes a rhesus macaque CD8+ T cell clone with maintenance of surface marker phenotype and function.

Authors:  Hanne Andersen; Eugene V Barsov; Matthew T Trivett; Charles M Trubey; Luis D Giavedoni; Jeffrey D Lifson; David E Ott; Claes Ohlén
Journal:  AIDS Res Hum Retroviruses       Date:  2007-03       Impact factor: 2.205

9.  The Mamu B 17-restricted SIV Nef IW9 to TW9 mutation abrogates correct epitope processing and presentation without loss of replicative fitness.

Authors:  Jacob T Minang; Matthew T Trivett; Lori V Coren; Eugene V Barsov; Michael Piatak; Oleg Chertov; Elena Chertova; David E Ott; Claes Ohlen
Journal:  Virology       Date:  2008-03-06       Impact factor: 3.616

10.  The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

Authors:  Rafick-Pierre Sekaly
Journal:  J Exp Med       Date:  2008-01-14       Impact factor: 14.307

View more
  28 in total

1.  Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.

Authors:  Vainav Patel; Antonio Valentin; Viraj Kulkarni; Margherita Rosati; Cristina Bergamaschi; Rashmi Jalah; Candido Alicea; Jacob T Minang; Matthew T Trivett; Claes Ohlen; Jun Zhao; Marjorie Robert-Guroff; Amir S Khan; Ruxandra Draghia-Akli; Barbara K Felber; George N Pavlakis
Journal:  Vaccine       Date:  2010-05-06       Impact factor: 3.641

2.  Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.

Authors:  Jeffrey D Lifson; Nancy L Haigwood
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

3.  HIV neutralizing antibodies: clinical correlates and implications for vaccines.

Authors:  Nicole A Doria-Rose
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

4.  TCR triggering transcriptionally downregulates CCR5 expression on rhesus macaque CD4(+) T-cells with no measurable effect on susceptibility to SIV infection.

Authors:  Jacob T Minang; Matthew T Trivett; Eugene V Barsov; Gregory Q Del Prete; Charles M Trubey; James A Thomas; Robert J Gorelick; Michael Piatak; David E Ott; Claes Ohlen
Journal:  Virology       Date:  2010-10-28       Impact factor: 3.616

5.  A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells.

Authors:  C Berger; M Berger; D Anderson; S R Riddell
Journal:  J Med Primatol       Date:  2010-11-02       Impact factor: 0.667

Review 6.  Kill: boosting HIV-specific immune responses.

Authors:  Lydie Trautmann
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

7.  Expansion of Simian Immunodeficiency Virus (SIV)-Specific CD8 T Cell Lines from SIV-Naive Mauritian Cynomolgus Macaques for Adoptive Transfer.

Authors:  Mariel S Mohns; Justin M Greene; Brian T Cain; Ngoc H Pham; Emma Gostick; David A Price; David H O'Connor
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

8.  HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo.

Authors:  Aude G Chapuis; Corey Casper; Steve Kuntz; Jia Zhu; Annelie Tjernlund; Kurt Diem; Cameron J Turtle; Melinda L Cigal; Roxanne Velez; Stanley Riddell; Lawrence Corey; Philip D Greenberg
Journal:  Blood       Date:  2011-03-21       Impact factor: 22.113

9.  Adoptive transfer of lymphocytes isolated from simian immunodeficiency virus SIVmac239Δnef-vaccinated macaques does not affect acute-phase viral loads but may reduce chronic-phase viral loads in major histocompatibility complex-matched recipients.

Authors:  Justin M Greene; Jennifer J Lhost; Paul J Hines; Matthew Scarlotta; Max Harris; Benjamin J Burwitz; Melisa L Budde; Dawn M Dudley; Ngoc Pham; Brian Cain; Caitlin E Mac Nair; Madelyn K Weiker; Shelby L O'Connor; Thomas C Friedrich; David H O'Connor
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

10.  Diverse peptide presentation of rhesus macaque major histocompatibility complex class I Mamu-A 02 revealed by two peptide complex structures and insights into immune escape of simian immunodeficiency virus.

Authors:  Jun Liu; Lianpan Dai; Jianxun Qi; Feng Gao; Youjun Feng; Wenjun Liu; Jinghua Yan; George F Gao
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.